← All organizations
Highest phase reached
Phase 4
First clinical trial
Nov 1, 2010Last known activity
Sep 29, 2025
Timeline
1890s
- Jan 1, 1890
PT Bio Farma— Founded
Drugs by trial phase (28 distinct, 41 trials)
Phase 4 (7 own, 0 via acquisition)
Phase 3 (12 own, 0 via acquisition)
- diphtheria-tetanus-whole cell pertussis-inactivated poliovirus-haemophilus influenzae b conjugate-hepatitis b vaccine
- hydroxychloroquine
- hepatitis b vaccine (recombinant)
- typhoid vi polysaccharide vaccine
- apixaban
- haemophilus influenzae type b conjugate vaccine
- acellular pertussis vaccine (including diptheria and tetanus toxoids)
- vi-dt typhoid conjugate vaccine
- pqed typhoid conjugate vaccine
- rotavirus rv3 vaccine
- inactivated SARS-Cov-2 vaccine
- sars-cov-2 protein subunit recombinant vaccine PT Biopharma
Phase 2 (5 own, 0 via acquisition)
Phase 1 (4 own, 0 via acquisition)
Indications
Recent trials (43)
- NCT06895486CollaboratorPhase 2Sep 29, 2025
- NCT06690515Lead sponsorPhase 1/Phase 2Mar 1, 2025
- NCT05933278Lead sponsorPhase 2Jul 31, 2023
- NCT06114641Lead sponsorPhase 4Jun 1, 2023
- NCT05654467CollaboratorPhase 2May 29, 2023
- NCT05727215Lead sponsorPhase 2Feb 28, 2023
- NCT05644184CollaboratorPhase 2Feb 28, 2023
- NCT06053853Lead sponsorPhase 4Jan 31, 2023
- NCT05482282Lead sponsorPhase 3Oct 31, 2022
- NCT05482295Lead sponsorPhase 3Oct 31, 2022
- NCT05546502Lead sponsorPhase 3Oct 9, 2022
- NCT05525208Lead sponsorPhase 2Sep 1, 2022
- NCT05433285Lead sponsorPhase 3Jun 7, 2022
- NCT05313035Lead sponsorPhase 2/Phase 3Apr 13, 2022
- NCT05124340Lead sponsorPhase 2Dec 15, 2021
Details
- Founded
- Bandung, ID Jan 1, 1890
- Last known activity
- Sep 29, 2025